Return

Revvity

Branche
Laboratory Technology
Impossible is inspiration
If they say “impossible,” we say “challenge accepted.” At Revvity, we fearlessly face tomorrow's unknowns for a healthier humankind.
We're building on a legacy of innovation and commitment to revolutionizing health science. Working together, we've already impacted health worldwide in many ways, including:
  • 700 peer-reviewed publications describing our TB test as demonstrating excellent performance in a wide variety of settings
  • Providing workflows that enabled the testing of more than 75 million individuals for COVID-19
  • Introducing over 1,500 new antibodies, kits, and reagents annually for life science research
  • Supplying more than two million scientists across pharma, biotech, and academia with Revvity's software solutions
  • Screening 40 million babies annually for life-threatening diseases across 110 countries
As a team of more than 11,000 employees across 190 countries, we offer both scale and agility. United, we can deliver custom, complete solutions from discovery to development, and diagnosis to cure.
Combined with our rapidly growing strength in automation, productivity, and workflow, we are uniquely positioned to accelerate health science innovation from bench to bedside. And this is just the beginning.
Our specialized areas of focus include translational multi-omics technologies, biomarker identification, imaging, prediction, screening and diagnosis, detection, informatics, and more.

Contact

Revvity Rigaweg 22 9723 TH Groningen Tel: 0800 0234490 jonathan slade
Visit the website

Related events

WoTS

FHI
Name
Hidden
Dit veld is bedoeld voor validatiedoeleinden en moet niet worden gewijzigd.
© FHI 2024
FHI, federatie van technologiebranches
nl_NLNederlands
nl_NLNederlands